Analysis of head-up tilt test responses in patients suffering from syncope and high blood pressure;Análisis de la respuesta al test de tabla basculante de los pacientes con síncope que presentan hipertensión arterial

Revista Espanola de Cardiologia

Volumn 59, Issue 1, 2006, Pages 68-71

  Barón Esquivias, Gonzalo ^a   Gómez, Silvia ^a   Cayuela, Aurelio ^a   Valle, Juan I ^a   Pedrote, Alonso ^b   Martínez, Ángel ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b NONE   (Spain)

Author keywords

Arterial hypertension; Syncope; Tilt test

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLYCERYL TRINITRATE; HYPERTENSIVE FACTOR; VASODILATOR AGENT;

ADULT; AGE; AGED; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE DURATION; FEMALE; HEAD TILTING; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREVALENCE; SYMPTOM; SYNCOPE;

EID: 33344469702     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13083652     Document Type: Article

References (11)

1. Soteriades ES, Evans JC, Larson MG, Chen MH, Chen L, Benjamin EJ, et al. Incidence and prognosis of syncope. N Engl J Med. 2002;347:878-85.
2. Chen L, Chen MH, Larson MG, Evans J, Benjamin EJ, Levy D. Risk factors for syncope in a community-based sample (the Framingham heart study). Am J Cardiol. 2000;85:1189-93.
3. Task Force Report. Guidelines on management (diagnosis and treatment) of syncope. Eur Heart J. 2001;22:1256-306.
4. Moya I, Mitjans A. La prueba en tabla basculante en el síncope vasovagal, ¿para qué?, ¿a quién? Rev Esp Cardiol. 2002;55:466-8.
5. Barón-Esquivias G, Pedrote A, Cayuela A, Valle JI, Fernández JM, Estepa MJ, et al. Age and gender differences in basal and isoprenaline protocols for head-up tilt table testing. Europace. 2001;3:136-40.
6. Barón-Esquivias G, Pedrote A, Cayuela A, Cabezón S, Morán JE, Errázquin F. Características clínicas y resultados del test de tabla basculante utilizando tres protocolos en 1.661 pacientes con síncope. Rev Esp Cardiol. 2003;56:916-20.
7. Barón-Esquivias G, Pedrote A, Errazquin F. Anomalous result and worsening of vasovagal syncope after a therapeutic regime with metoprolol guided by head-up tilt test. Eur J Card Pacing Electrophysiol. 1996;6:60-1.
8. Bartoletti A, Alboni P, Ammirati F, Brignole M, Del Rosso A, Foglia Manzillo G, et al. «The Italian protocolo»: a simplified head-up tilt testing potentiated with oral nitroglycerin to assess patients with unexplained syncope. Europace. 2000;2:339-42.
9. Barón-Esquivias G, Errazquin F, Pedrote A, Cayuela A, Gómez S, Aguilera A, et al. Long term follow-up of patients with vasovagal syncope. Am Heart J. 2004;147:883-9.
10. Freed LA, Eagle KA, Mahjoub ZA, Gold MR, Smith AJC, Bjork L, et al. Gender differences in presentation, management, and cardiac event-free survival in patients with syncope. Am J Cardiol. 1997;80:1183-7.
11. Gaggiolo G, Bottani N, Mureddu R, Foglia-Monzillo G, Mascioli G, Bartola P, et al. Effects of chronic vasodilatador therapy to enhance susceptibility to vasovagal syncope during upright tilt testing. Am J Cardiol. 1997;80:1092-4.